诺和诺德针对自费患者推出低于礼来的肥胖症药物定价。诺和诺德将以每月349美元价格在美国销售司美格鲁肽口服制剂(Wegovy)和司美格鲁肽注射液(Ozempic)。 。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.